Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: allogeneic large multivalent immunogen breast cancer vaccine|BIOLOGICAL: aldesleukin
Sponsor: Masonic Cancer Center, University of Minnesota